首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

2126703

肝炎疫苗市場：依適應症、疫苗類型、通路和地區分類。

Hepatitis Vaccine Market, By Indication, By Vaccine Type, By Distribution Channel, By Geography

出版日期: 2026年08月04日 | 出版商:

Coherent Market Insights | 英文 255 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，到2026年，肝炎疫苗市場規模將達到35.1億美元，預計2033年將達到45億美元。預計從2026年到2033年，其複合年成長率將達到3.63%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	35.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	3.63	2033年市場規模預測：	45億美元

肝炎疫苗市場正經歷顯著的變革，其主要驅動力包括全球肝炎感染病例的增加、政府對免疫接種計劃的重視程度提高、公眾健康意識的增強、疫苗技術的進步以及對有效疾病預防方案日益成長的需求。該市場涵蓋多種不同類型肝炎的疫苗，包括甲型肝炎疫苗、B型肝炎疫苗以及可預防多種肝炎病毒的聯合疫苗。常規兒童免疫接種計劃、成人免疫接種計劃、旅行疫苗接種要求以及旨在減輕肝炎相關併發症（如肝硬化和肝癌）的公共衛生宣傳活動，都為該市場的發展提供了支持。

此外，重組疫苗技術的進步、疫苗配方的改進、成人和兒童免疫接種計劃的擴大、旅行疫苗接種要求以及發展中地區醫療保健投入的增加，也都在推動這一市場的發展。各國政府、醫療機構和疫苗生產商正致力於提高疫苗的可及性、降低疫苗價格並完善分銷網路，以減輕肝炎相關併發症（如肝硬化和肝癌）的發生。預計這些趨勢將加強肝炎預防工作，並推動肝炎疫苗市場的長期成長。

市場動態

由於肝炎感染率不斷上升、公眾健康意識增強、免疫接種計劃不斷擴大以及對有效疫苗以減輕肝炎相關併發症的需求日益成長，肝炎疫苗市場正經歷顯著成長。推動市場擴張的主要力量來自各國政府、公共衛生機構、醫院、免疫接種中心、小兒科、感染疾病專家和研究機構，他們致力於改善疾病預防、提高免疫接種率並支持全球肝炎根除舉措。疫苗研發、重組疫苗技術、聯合疫苗和分銷系統的進步在提高疫苗效力、可及性和長期保護效果方面發揮著至關重要的作用。

醫療保健計畫的擴展和大規模免疫接種舉措正在推動肝炎疫苗市場的成長。這一成長主要得益於甲型肝炎疫苗、乙型肝炎疫苗、甲乙聯合疫苗以及兒童和成人免疫接種計劃的推廣，以及政府支持的肝炎預防宣傳活動。這些免疫接種措施透過降低感染率、預防肝硬化和肝癌等嚴重肝臟疾病以及提供針對肝炎病毒的早期預防，有助於改善公眾健康狀況。

此外，全球對疾病預防的日益重視、醫療保健服務的改善以及以患者為中心的疫苗接種策略正在加速市場成長。製藥公司、疫苗生產商、政府機構、醫院、公共衛生組織和研究機構在先進肝炎疫苗的研發和推廣中發揮著至關重要的作用。隨著疫苗技術、免疫策略和感染疾病控制研究的不斷深入，市場有望受益於醫療保健投資的增加、免疫基礎設施的完善、目標人口的擴大以及更有效、更易獲得的疫苗解決方案的推出。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了肝炎疫苗市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使行銷負責人和企業經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份肝炎疫苗市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用肝炎疫苗市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Merck and Company
- GlaxoSmithKline
- Sanofi Pasture
- CSL Behring GmbH
- Novartis AG
- Pfizer Inc.
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1537

Hepatitis Vaccine Market is estimated to be valued at USD 3.51 Bn in 2026 and is expected to reach USD 4.50 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.63% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.51 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.63%	2033 Value Projection:	USD 4.50 Bn

The hepatitis vaccine market is undergoing significant transformation, primarily driven by the increasing prevalence of hepatitis infections worldwide, rising government initiatives for immunization programs, growing awareness about preventive healthcare, advancements in vaccine technologies, and increasing demand for effective disease prevention solutions. The market includes a broad range of vaccines targeting different types of hepatitis, including Hepatitis A vaccines, Hepatitis B vaccines, and combination vaccines that provide protection against multiple hepatitis viruses. The market is supported by routine childhood vaccination programs, adult immunization initiatives, travel vaccination requirements, and public health campaigns aimed at reducing hepatitis-related complications such as liver cirrhosis and liver cancer.

The market is further supported by advancements in recombinant vaccine technology, improved vaccine formulations, expanded adult and pediatric immunization programs, travel vaccination requirements, and increased healthcare investments in developing regions. Governments, healthcare organizations, and vaccine manufacturers are focusing on improving vaccine accessibility, affordability, and distribution networks to reduce hepatitis-related complications such as liver cirrhosis and liver cancer. These developments are expected to strengthen hepatitis prevention efforts and drive the long-term growth of the Hepatitis Vaccine Market.

Market Dynamics

The hepatitis vaccine market is witnessing significant growth due to the increasing prevalence of hepatitis infections, rising awareness of preventive healthcare, growing adoption of immunization programs, and increasing demand for effective vaccines to reduce hepatitis-related complications. Market expansion is largely driven by governments, public health organizations, hospitals, vaccination centers, pediatricians, infectious disease specialists, and research institutions focusing on improving disease prevention, increasing vaccination coverage, and supporting global hepatitis elimination initiatives. Advancements in vaccine development, recombinant vaccine technologies, combination vaccines, and improved distribution systems are playing an important role in enhancing vaccine effectiveness, accessibility, and long-term protection.

The expansion of preventive healthcare programs and large-scale immunization initiatives is fueling the growth of the Hepatitis Vaccine Market. This growth is mainly driven by increasing adoption of Hepatitis A vaccines, Hepatitis B vaccines, combination Hepatitis A and B vaccines, and childhood and adult vaccination programs, along with government-supported hepatitis prevention campaigns. These vaccination approaches help reduce infection rates, prevent severe liver diseases such as cirrhosis and liver cancer, and improve public health outcomes through early protection against hepatitis viruses.

The growing focus on global disease prevention, healthcare accessibility, and patient-centered vaccination strategies is also accelerating market growth. Pharmaceutical companies, vaccine manufacturers, government agencies, hospitals, public health organizations, and research institutions play a key role in developing and expanding the availability of advanced hepatitis vaccines. As research in vaccine technology, immunization strategies, and infectious disease management continues to advance, the market is expected to benefit from increased healthcare investments, improved vaccination infrastructure, wider population coverage, and the introduction of more effective and accessible vaccine solutions.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Hepatitis Vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck and Company, GlaxoSmithKline, Sanofi Pasture, CSL Behring GmbH, Novartis AG and Pfizer Inc. Few leading brands in hepatitis vaccine market are Engerix-B, Havrix (Glaxosmithkline), Recombivax, Vaqta (Merck and Company), Euvax - Avaxim (Sanofi Pasteur), and Shanvac B (Shantha Biotech)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Hepatitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Hepatitis Vaccine Market

Market Segmentation

By Indication (Revenue, USD Bn, 2021-2033)
Hepatitis A
Hepatitis B
By Vaccine Type (Revenue, USD Bn, 2021-2033)
Recombinant Vaccine
Inactivated Vaccine
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospitals
Retail Pharmacy
Online Pharmacy
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players Insights
Merck and Company
GlaxoSmithKline
Sanofi Pasture
CSL Behring GmbH
Novartis AG and Pfizer Inc
Engerix-B
Havrix (Glaxosmithkline)
Recombivax
Vaqta (Merck and Company)
Euvax - Avaxim (Sanofi Pasteur)
Shanvac B (Shantha Biotech)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Hepatitis Vaccine Market, By Indication, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hepatitis A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Hepatitis B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Hepatitis Vaccine Market, By Vaccine Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Hepatitis Vaccine Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Hepatitis Vaccine Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Merck and Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GlaxoSmithKline
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi Pasture
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- CSL Behring GmbH
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views